Marico Q1 FY27 Business Update (3 July 2026)

Marico Ltd, a large‑cap FMCG player, released its Q1 FY27 update on 3 July 2026. The stock traded up to Rs 874.00, a 2.0% gain from the prior close of Rs 856.25, giving the company a market capitalisation of Rs 1,09,194.30 crore.

The quarter’s consolidated revenue reached Rs 3,333 crore, marking a 22.09% increase over the Rs 2,730 crore recorded in Q4 FY2025. Net profit rose to Rs 408 crore from Rs 345 crore in the same prior period. The firm highlighted double‑digit volume growth in India, led by Parachute Coconut Oil, which posted its strongest performance in several quarters. Value‑Added Hair Oils and newer categories such as Foods and Premium Personal Care also scaled, while Saffola Oils recorded revenue growth but lower volumes due to selective supply optimisation.

International operations delivered constant‑currency growth in the mid‑teens, driven primarily by Vietnam and the MENA region. Bangladesh, however, showed temporary moderation because of pricing effects and softer demand in a high‑inflation environment. Overall, the company expects consolidated revenue to expand in the early twenties, underpinned by broad‑based strength across core and emerging businesses.

On the cost side, rising crude‑linked and vegetable‑oil inputs were partially offset by a sharp correction in copra prices, which are down roughly 45% from peak levels but remain above historical averages. This price decline is expected to improve gross margins sequentially and support margin recovery.

Broker Commentary

  • Morgan Stanley retained an Overweight rating, set a target price of Rs 934, and indicated a 9% upside from the previous close. The brokerage noted that Q1 topline growth exceeded expectations and emphasized EBITDA growth as the key metric, while flagging inflation and El Niño‑related monsoon impacts as monitorable risks.
  • JPMorgan also kept an Overweight stance with a Rs 900 target price and a 5% upside potential. It highlighted the revenue beat, driven by strong volume growth, and projected EBITDA growth in the high‑teens, citing resilient operating performance and improving demand trends.
  • Macquarie Group maintained an Outperform rating, targeting Rs 890 and a 4% upside. The firm described the pre‑quarter update as better than expected, forecasting about 15% EBITDA growth in Q1, driven by steady operational recovery and improving demand momentum.
  • Goldman Sachs upheld a Buy rating with a Rs 900 target price and a 5% upside. It pointed to double‑digit volume growth led by Parachute, continued momentum in Value‑Added Hair Oils and newer businesses, and expected EBITDA growth in the high‑teens supported by sequential margin recovery.

All four brokerages anticipate high‑teens EBITDA growth, indicating operating leverage from stronger volumes and an improving product mix.

Financial Strength

Marico’s capital efficiency remains robust, with a Return on Capital Employed (ROCE) of 47.2% and a Return on Equity (ROE) of 43.0%, the latter consistent with an average of around 41% over the past three years. The company’s debt‑to‑equity ratio stands at a conservative 0.13, reflecting limited reliance on borrowed funds. Shareholder returns are highlighted by a dividend payout of approximately 65.1%.

For FY 2025‑26, Marico reported a turnover of about ₹136.1 billion (≈ USD 1.5 billion), with its international consumer business contributing roughly 24% of total revenue. The portfolio includes flagship brands such as Parachute, Saffola, Hair & Care, Parachute Advansed, Nihar Naturals, Mediker, Set Wet, Livon, Beardo, Just Herbs, True Elements, Plix, and Cosmix, while overseas brands like HairCode, Fiancée, Purité de Provence, Ôliv, Caivil, Hercules, and Isoplus bolster its global footprint.

Risks

The update flags macro‑level risks including persistent inflation, monsoon variability, and weakness in select international markets, which could temper the pace of earnings improvement.

---